Contemporary Management of Oropharyngeal Cancer

Current Problems in Surgery

Volumn 46, Issue 2, 2009, Pages 119-184

  Duvvuri, Umamaheswar ^a   Myers, Jeffrey N ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; CYTOTOXIC AGENT; FLUORODEOXYGLUCOSE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; NARCOTIC ANALGESIC AGENT; PACLITAXEL; PLATINUM COMPLEX; TAXANE DERIVATIVE; TIRAPAZAMINE;

ACNE; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ALCOHOL CONSUMPTION; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER INVASION; CANCER MORPHOLOGY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CERVICAL FIBROSIS; CERVICAL LYMPHADENOPATHY; CIGARETTE SMOKING; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; DRUG MEGADOSE; DYSPHAGIA; EAR NOSE THROAT SURGERY; ENDOSCOPY; ENVIRONMENTAL EXPOSURE; ERYTHROPLASIA; FEEDING APPARATUS; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INTENSITY MODULATED RADIATION THERAPY; LABORATORY TEST; LEUKOPLAKIA; LICHEN PLANUS; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOEPITHELIOMA; MANDIBLE RESECTION; MICROSURGERY; MOLECULAR EPIDEMIOLOGY; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; NEUTRON THERAPY; NONHUMAN; OROPHARYNX CANCER; OVERALL SURVIVAL; PHYSICAL EXAMINATION; PLASTIC SURGERY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRECANCER; PROGNOSIS; SALIVARY GLAND TUMOR; SARCOMA; SEXUAL BEHAVIOR; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURGICAL ANATOMY; SURGICAL APPROACH; SURVIVAL RATE; VERRUCOUS CARCINOMA; VIRUS PATHOGENESIS; WART VIRUS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; DEGLUTITION DISORDERS; ENTERAL NUTRITION; HUMAN PAPILLOMAVIRUS 16; HUMANS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; OROPHARYNX; PAPILLOMAVIRUS INFECTIONS; TREATMENT OUTCOME;

EID: 57849166210     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2008.10.003     Document Type: Article

References (139)

1. Rouviere H. Anatomie des lymphatiques de l'homme (1932), Masson, Paris
2. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29 (1972) 1446-1449
3. Ballantyne A.J. Significance of retropharyngeal nodes in cancer of the head and neck. Am J Surg 108 (1964) 500-504
4. Califano J., van der Riet P., Westra W., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 (1996) 2488-2492
5. Forastiere A., Koch W., Trotti A., et al. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
6. Ha P.K., and Califano J.A. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 7 (2006) 77-82
7. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
8. Gassner H.G., Sabri A.N., and Olsen K.D. Oropharyngeal malignancy. In: Cummings C.W. (Ed). Cummings' Otolaryngology-Head & Neck Surgery (2005), Mosby, St Louis
9. Marur S., and Forastiere A.A. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 83 (2008) 489-501
10. Werness B.A., Levine A.J., and Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990) 76-79
11. Dyson N., Howley P.M., Munger K., et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 (1989) 934-937
12. Munoz N., Bosch F.X., de Sanjose S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
13. D'Souza G., Kreimer A.R., Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356 (2007) 1944-1956
14. Gillison M.L., D'Souza G., Westra W., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100 (2008) 407-420
15. Kreimer A.R., Clifford G.M., Boyle P., et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14 (2005) 467-475
16. Herrero R., Castellsague X., Pawlita M., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95 (2003) 1772-1783
17. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 (2000) 709-720
18. Wiest T., Schwarz E., Enders C., et al. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21 (2002) 1510-1517
19. Begum S., Gillison M.L., Ansari-Lari M.A., et al. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 9 (2003) 6469-6475
20. Lindel K., Beer K.T., Laissue J., et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92 (2001) 805-813
21. Hansson B.G., Rosenquist K., Antonsson A., et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 125 (2005) 1337-1344
22. Mork J., Lie A.K., Glattre E., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344 (2001) 1125-1131
23. Chaturvedi A.K., Engels E.A., Anderson W.F., et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26 (2008) 612-619
24. Fleming D.T., McQuillan G.M., Johnson R.E., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337 (1997) 1105-1111
25. Weinberger P.M., Yu Z., Haffty B.G., et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24 (2006) 736-747
26. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 (2008) 261-269
27. Silverman Jr. S., Gorsky M., and Kaugars G.E. Leukoplakia, dysplasia, and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82 (1996) 117
28. Silverman Jr. S., Gorsky M., and Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53 (1984) 563-568
29. Schoelch M.L., Sekandari N., Regezi J.A., et al. Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 109 (1999) 949-953
30. Reichart P.A., and Philipsen H.P. Oral erythroplakia-a review. Oral Oncol 41 (2005) 551-561
31. Conte C.C., Ergin M.T., Ricci Jr. A., et al. Clinical and pathologic prognostic variables in oropharyngeal squamous cell carcinoma. Am J Surg 157 (1989) 582-584
32. Fagan J.J., Collins B., Barnes L., et al. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 124 (1998) 637-640
33. Rahima B., Shingaki S., Nagata M., et al. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 (2004) 423-431
34. Hafkamp H.C., Manni J.J., and Speel E.J. Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol 124 (2004) 520-526
35. Poetsch M., Lorenz G., Bankau A., et al. Basaloid in contrast to nonbasaloid head and neck squamous cell carcinomas display aberrations especially in cell cycle control genes. Head Neck 25 (2003) 904-910
36. Beckhardt R.N., Weber R.S., Zane R., et al. Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope 105 (1995) 1155-1160
37. Garden A.S., Weber R.S., Ang K.K., et al. Postoperative radiotherapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer 73 (1994) 2563-2569
38. Laramore G.E., Krall J.M., Griffin T.W., et al. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiotherapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys 27 (1993) 235-240
39. Pogodzinski M.S., Sabri A.N., Lewis J.E., et al. Retrospective study and review of polymorphous low-grade adenocarcinoma. Laryngoscope 116 (2006) 2145-2149
40. Cinberg J.Z., Silver C.E., Molnar J.J., et al. Cervical cysts: cancer until proven otherwise?. Laryngoscope 92 (1982) 27-30
41. Gourin C.G., and Johnson J.T. Incidence of unsuspected metastases in lateral cervical cysts. Laryngoscope 110 (2000) 1637-1641
42. Randall D.A., Johnstone P.A., Foss R.D., et al. Tonsillectomy in diagnosis of the unknown primary tumor of the head and neck. Otolaryngol Head Neck Surg 122 (2000) 52-55
43. van Bokhorst-de van der Schueren M.A., van Leeuwen P.A., Sauerwein H.P., et al. Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck 19 (1997) 419-425
44. Feuerstein I.M., Jicha D.L., Pass H.I., et al. Pulmonary metastases: MR imaging with surgical correlation-a prospective study. Radiology 182 (1992) 123-129
45. Hsu W.C., Loevner L.A., Karpati R., et al. Accuracy of magnetic resonance imaging in predicting absence of fixation of head and neck cancer to the prevertebral space. Head Neck 27 (2005) 95-100
46. Righi P.D., Kelley D.J., Ernst R., et al. Evaluation of prevertebral muscle invasion by squamous cell carcinoma. Can computed tomography replace open neck exploration?. Arch Otolaryngol Head Neck Surg 122 (1996) 660-663
47. Braams J.W., Pruim J., Kole A.C., et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg 26 (1997) 112-115
48. Miller F.R., Karnad A.B., Eng T., et al. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 30 (2008) 28-34
49. Fleming Jr. A.J., Smith Jr. S.P., Paul C.M., et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 117 (2007) 1173-1179
50. Chung T.S., and Stefani S. Distant metastases of carcinoma of tonsillar region: a study of 475 patients. J Surg Oncol 14 (1980) 5-9
51. Koch W.M., Bhatti N., Williams M.F., et al. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 124 (2001) 331-333
52. Selek U., Garden A.S., Morrison W.H., et al. Radiotherapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 59 (2004) 743-751
53. Fu K.K., Pajak T.F., Trotti A., et al. A Radiotherapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
54. Ding M., Newman F., and Raben D. New radiotherapy techniques for the treatment of head and neck cancer. Otolaryngol Clin North Am 38 (2005) 371-395, vii-viii.
55. Garden A.S., Morrison W.H., Wong P.F., et al. Disease-control rates following intensity-modulated radiotherapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67 (2007) 438-444
56. Hodge C.W., Bentzen S.M., Wong G., Palazzi-Churas K.L., Wiederholt P.A., Gondi V., et al. Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy?. An inter-era comparison. Int J Radiat Oncol Biol Phys 69 (2007) 1032-1041
57. Sterzing F., Herfarth K., and Debus J. IGRT with helical tomotherapy-effort and benefit in clinical routine. Strahlenther Onkol 183 Spec No. 2 (2007) 35-37
58. Sterzing F., Schubert K., Sroka-Perez G., et al. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 184 (2008) 8-14
59. Dawson L.A., and Sharpe M.B. Image-guided radiotherapy: rationale, benefits, and limitations. Lancet Oncol 7 (2006) 848-858
60. Le Scodan R., Pommier P., Ardiet J.M., et al. Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients. Int J Radiat Oncol Biol Phys 63 (2005) 441-448
61. Narayana A., Cohen G.N., Zaider M., et al. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers-preliminary results. Brachytherapy 6 (2007) 157-163
62. Son Y.H., and Sasaki C.T. Nonsurgical alternative therapy for bulky advanced head and neck tumors. Arch Otolaryngol Head Neck Surg 121 (1995) 991-993
63. Vikram B., and Mishra S. Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins. Head Neck 16 (1994) 155-157
64. Vikram B., and Mishra S. Permanent iodine-125 (I-125) boost implants after external radiotherapy in nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 28 (1994) 699-701
65. Harrison L.B., Lee H.J., Pfister D.G., et al. Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue. Head Neck 20 (1998) 668-673
66. Nose T., Koizumi M., and Nishiyama K. High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phys 59 (2004) 983-991
67. Hu K., and Harrison L.B. Point: brachytherapy versus intensity-modulated radiation therapy in the management of base of tongue cancers. Brachytherapy 4 (2005) 1-4
68. Pernot M., Malissard L., Hoffstetter S., et al. The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 29 (1994) 673-679
69. Pernot M., Malissard L., Taghian A., et al. Velotonsillar squamous cell carcinoma: 277 cases treated by combined external irradiation and brachytherapy-results according to extension, localization, and dose rate. Int J Radiat Oncol Biol Phys 23 (1992) 715-723
70. Douglas J.G., Koh W.J., Austin-Seymour M., et al. Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch Otolaryngol Head Neck Surg 129 (2003) 944-948
71. Douglas J.G., Laramore G.E., Austin-Seymour M., et al. Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy. Int J Radiat Oncol Biol Phys 46 (2000) 551-557
72. Douglas J.G., Laramore G.E., Austin-Seymour M., et al. Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands. Int J Radiat Oncol Biol Phys 36 (1996) 87-93
73. Huber P.E., Debus J., Latz D., et al. Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?. Radiother Oncol 59 (2001) 161-167
74. Catterall M., and Errington R.D. The implications of improved treatment of malignant salivary gland tumors by fast neutron radiotherapy. Int J Radiat Oncol Biol Phys 13 (1987) 1313-1318
75. Catterall M., Errington R.D., and Bewley D.K. A comparison of clinical and laboratory data on neutron therapy for locally advanced tumors. Int J Radiat Oncol Biol Phys 13 (1987) 1783-1791
76. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiotherapy versus concomitant chemotherapy and radiotherapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 (1999) 2081-2086
77. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
78. Caudell J.J., Sawrie S.M., Spencer S.A., et al. Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys 71 (2008) 676-681
79. Posner M.R., Hershock D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
80. Vermorken J.B., Remenar E., van Herpen C., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 (2007) 1695-1704
81. Glisson B.S., Murphy B.A., Frenette G., et al. Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. J Clin Oncol 20 (2002) 1593-1599
82. Khuri F.R., Shin D.M., Glisson B.S., et al. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Semin Oncol 27 (2000) 25-33
83. Pivot X., Cals L., Cupissol D., et al. Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck. Oncology 60 (2001) 66-71
84. Vermorken J.B., Trigo J., Hitt R., et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 25 (2007) 2171-2177
85. Shedd D.P. Wilfred Trotter, head and neck surgeon and sociologist. Head Neck 18 (1996) 366-369
86. Holsinger F.C., McWhorter A.J., Menard M., et al. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results. Arch Otolaryngol Head Neck Surg 131 (2005) 583-591
87. Laccourreye O., Hans S., Menard M., et al. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence. Arch Otolaryngol Head Neck Surg 131 (2005) 592-599
88. Steiner W., Fierek O., Ambrosch P., et al. Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 129 (2003) 36-43
89. O'Malley Jr. B.W., Weinstein G.S., Snyder W., et al. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 116 (2006) 1465-1472
90. Weinstein G.S., O'Malley Jr. B.W., Snyder W., et al. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 133 (2007) 1220-1226
91. Hockstein N.G., O'Malley Jr. B.W., and Weinstein G.S. Assessment of intraoperative safety in transoral robotic surgery. Laryngoscope 116 (2006) 165-168
92. Kraus D.H., Vastola A.P., Huvos A.G., et al. Surgical management of squamous cell carcinoma of the base of the tongue. Am J Surg 166 (1993) 384-388
93. Shirazi H.A., Sivanandan R., Goode R., et al. Advanced-staged tonsillar squamous carcinoma: organ preservation versus surgical management of the primary site. Head Neck 28 (2006) 587-594
94. Lundahl R.E., Foote R.L., Bonner J.A., et al. Combined neck dissection and postoperative radiotherapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys 40 (1998) 529-534
95. Soo K.C., Tan E.H., Wee J., et al. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 93 (2005) 279-286
96. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
97. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
98. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
99. Winquist E., Oliver T., and Gilbert R. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis. Head Neck 29 (2007) 38-46
100. Duvvuri U., Simental Jr. A.A., D'Angelo G., et al. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope 114 (2004) 2228-2234
101. Wang M.B., Kuber N., Kerner M.M., et al. Tonsillar carcinoma: analysis of treatment results. J Otolaryngol 27 (1998) 263-269
102. Jones A.S., Roland N.J., Field J.K., et al. The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primary sites. Clin Otolaryngol Allied Sci 19 (1994) 63-69
103. Lim Y.C., Koo B.S., and Choi E.C. Bilateral neck node metastasis: a predictor of isolated distant metastasis in patients with oral and oropharyngeal squamous cell carcinoma after primary curative surgery. Laryngoscope 117 (2007) 1576-1580
104. Andersen P.E., Warren F., Spiro J., et al. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg 128 (2002) 1180-1184
105. Schiff B.A., Roberts D.B., El-Naggar A., et al. Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg 131 (2005) 874-878
106. Clayman G.L., Johnson II C.J., Morrison W., et al. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 127 (2001) 135-139
107. Lavertu P., Adelstein D.J., Saxton J.P., et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 19 (1997) 559-566
108. Lavertu P., Bonafede J.P., Adelstein D.J., et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 124 (1998) 401-406
109. Corry J., Smith J.G., and Peters L.J. The concept of a planned neck dissection is obsolete. Cancer J 7 (2001) 472-474
110. Corry J., Peters L., Fisher R., et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans-Tasman Radiation Oncology Group Study 98.02. Head Neck 30 (2008) 737-742
111. Gourin C.G., Williams H.T., Seabolt W.N., et al. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 116 (2006) 705-710
112. Liauw S.L., Mancuso A.A., Amdur R.J., et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 24 (2006) 1421-1427
113. Porceddu S.V., Jarmolowski E., Hicks R.J., et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27 (2005) 175-181
114. Simon C., Goepfert H., Rosenthal D.I., et al. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol 263 (2006) 313-318
115. Carroll W.R., Locher J.L., Canon C.L., et al. Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope 118 (2008) 39-43
116. Skoner J.M., Andersen P.E., Cohen J.I., et al. Swallowing function and tracheotomy dependence after combined-modality treatment including free tissue transfer for advanced-stage oropharyngeal cancer. Laryngoscope 113 (2003) 1294-1298
117. Shiley S.G., Hargunani C.A., Skoner J.M., et al. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 134 (2006) 455-459
118. Rosenthal D.I., Lewin J.S., and Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24 (2006) 2636-2643
119. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
120. Feng F.Y., Kim H.M., Lyden T.H., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 68 (2007) 1289-1298
121. Eisbruch A., Levendag P.C., Feng F.Y., et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer?. The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 69 (2007) S40-S42
122. Lees J. Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study. Eur J Cancer Care (Engl) 6 (1997) 45-49
123. Maccabee D., and Sheppard B.C. Prevention of percutaneous endoscopic gastrostomy stoma metastases in patients with active oropharyngeal malignancy. Surg Endosc 17 (2003) 1678
124. Gillespie M.B., Brodsky M.B., Day T.A., et al. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 114 (2004) 1362-1367
125. Beaver M.E., Matheny K.E., Roberts D.B., et al. Predictors of weight loss during radiotherapy. Otolaryngol Head Neck Surg 125 (2001) 645-648
126. Beaver M.E., Myers J.N., Griffenberg L., et al. Percutaneous fluoroscopic gastrostomy tube placement in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 124 (1998) 1141-1144
127. Agra I.M., Carvalho A.L., Ulbrich F.S., et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 28 (2006) 107-113
128. Goodwin Jr. W.J. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?. Laryngoscope 110 (2000) 1-18
129. Kao J., Garofalo M.C., Milano M.T., et al. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev 29 (2003) 21-30
130. Milano M.T., Vokes E.E., Salama J.K., et al. Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1096-1106
131. De Crevoisier R., Domenge C., Wibault P., et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer 91 (2001) 2071-2076
132. Machtay M., Rosenthal D.I., Chalian A.A., et al. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 59 (2004) 72-77
133. Dawson L.A., Myers L.L., Bradford C.R., et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 377-385
134. Langer C.J., Harris J., Horwitz E.M., et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Oncology Group Protocol 9911. J Clin Oncol 25 (2007) 4800-4805
135. Cohen E.E., Rosine D., Haraf D.J., et al. Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 67 (2007) 678-684
136. In: Cummings C., Fredrickson J.M., Harker L.A., et al. (Eds). Otolaryngology Head and Neck Surgery. 2nd ed (1993), Mosby Year Book, St. Louis
137. In: Haagensen C.D., Feind C.R., Herter F.P., et al. (Eds). The Lymphatics in Cancer (1972), Saunders, Philadelphia
138. National Cancer Institute website. http://www.cancer.gov/cancertopics/pdq/treatment/oropharyngeal/HealthProfessional
139. In: Cummings C.W., Flint P.W., Harker L.A., et al. (Eds). Cummings Otolaryngology Head and Neck Surgery. 4th ed (2004), Mosby Inc, Philadelphia